|
1
|
Picker SM: In-vitro assessment of platelet
function. Transfus Apher Sci. 44:305–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klinger MH and Jelkmann W: Role of blood
platelets in infection and inflammation. J Interferon Cytokine Res.
22:913–922. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Othman M, Labelle A, Mazzetti I, Elbatarny
HS and Lillicrap D: Adenovirus-induced thrombocytopenia: the role
of von Willebrand factor and P-selectin in mediating accelerated
platelet clearance. Blood. 109:2832–2839. 2007.PubMed/NCBI
|
|
4
|
Youssefian T, Drouin A, Massé JM, Guichard
J and Cramer EM: Host defense role of platelets: engulfment of HIV
and Staphylococcus aureus occurs in a specific subcellular
compartment and is enhanced by platelet activation. Blood.
99:4021–4029. 2002. View Article : Google Scholar
|
|
5
|
Senzel L, Gnatenko DV and Bahou WF: The
platelet proteome. Curr Opin Hematol. 16:329–333. 2009. View Article : Google Scholar
|
|
6
|
Zhang Y and Bergelson JM: Adenovirus
receptors. J Virol. 79:12125–12131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Faraday N, Rade JJ, Johns DC, Khetawat G,
Noga SJ, DiPersio JF, Jin Y, Nichol JL, Haug JS and Bray PF: Ex
vivo cultured megakaryocytes express functional glycoprotein
IIb–IIIa receptors and are capable of adenovirus-mediated transgene
expression. Blood. 94:4084–4092. 1999.PubMed/NCBI
|
|
8
|
Triantafilou K, Triantafilou M, Takada Y
and Fernandez N: Human parechovirus 1 utilizes integrins
alphavbeta3 and alphavbeta1 as receptors. J Virol. 74:5856–5862.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni
S and Lieber A: Adenovirus-platelet interaction in blood causes
virus sequestration to the reticuloendothelial system of the liver.
J Virol. 81:4866–4871. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eggerman TL, Mondoro TH, Lozier JN and
Vostal JG: Adenoviral vectors do not induce, inhibit, or potentiate
human platelet aggregation. Hum Gene Ther. 13:125–128. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gray GC, McCarthy T, Lebeck MG, et al:
Genotype prevalence and risk factors for severe clinical adenovirus
infection, United States 2004–2006. Clin Infect Dis. 45:1120–1131.
2007.PubMed/NCBI
|
|
12
|
Lebeck MG, McCarthy TA, Capuano AW,
Schnurr DP, Landry ML, Setterquist SF, Heil GL, Kilic S and Gray
GC: Emergent US adenovirus 3 strains associated with an epidemic
and serious disease. J Clin Virol. 46:331–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shang L, Qu Z, Sun L, Wang Y, Liu F, Wang
S, Gao H and Jiang F: Astragaloside IV inhibits adenovirus
replication and apoptosis in A549 cells in vitro. J Pharm
Pharmacol. 63:688–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Angeles Marcos M, Camps M, Pumarola T,
Antonio Martinez J, Martinez E, Mensa J, Garcia E, Peñarroja G,
Dambrava P, Casas I, Jiménez de Anta MT and Torres A: The role of
viruses in the aetiology of community-acquired pneumonia in adults.
Antivir Ther. 11:351–359. 2006.
|
|
15
|
Maurice A, Marchand-Arvier M, Edert D, Le
Faou A, Gondrexon G and Vigneron C: The virucidal effect of
platelet concentrates: preliminary study and first conclusions.
Platelets. 13:219–222. 2002.PubMed/NCBI
|
|
16
|
Basani RB, French DL, Vilaire G, Brown DL,
Chen F, Coller BS, Derrick JM, Gartner TK, Bennett JS and Poncz M:
A naturally occurring mutation near the amino terminus of alphaIIb
defines a new region involved in ligand binding to alphaIIbbeta3.
Blood. 95:180–188. 2000.
|
|
17
|
Shimaoka M and Springer TA: Therapeutic
antagonists and conformational regulation of integrin function. Nat
Rev Drug Discov. 2:703–716. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Plow EF, Haas TA, Zhang L, Loftus J and
Smith JW: Ligand binding to integrins. J Biol Chem.
275:21785–21788. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yakushkin VV, Zyuryaev IT, Khaspekova SG,
Sirotkina OV, Ruda MY and Mazurov AV: Glycoprotein IIb–IIIa content
and platelet aggregation in healthy volunteers and patients with
acute coronary syndrome. Platelets. 22:243–251. 2011.
|
|
20
|
Mazurov AV, Pevzner DV, Antonova OA,
Byzova TV, Khaspekova SG, Semenov AV, Vlasik TN, Samko AN,
Staroverov II and Ruda MY: Safety, inhibition of platelet
aggregation and pharmacokinetics of Fab’2 fragments of the
anti-glycoprotein IIb–IIIa monoclonal antibody FRaMon in high-risk
coronary angioplasty. Platelets. 13:465–477. 2002.
|
|
21
|
Appledorn DM, Kiang A, McBride A, Jiang H,
Seregin S, Scott JM, Stringer R, Kousa Y, Hoban M, Frank MM and
Amalfitano A: Wild-type adenoviruses from groups A-F evoke unique
innate immune responses, of which HAd3 and SAd23 are partially
complement dependent. Gene Ther. 15:885–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klinger JR, Sanchez MP, Curtin LA, Durkin
M and Matyas B: Multiple cases of life-threatening adenovirus
pneumonia in a mental health care center. Am J Respir Crit Care
Med. 157:645–649. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McEver RP, Beckstead JH, Moore KL,
Marshall-Carlson L and Bainton DF: GMP-140, a platelet
alpha-granule membrane protein, is also synthesized by vascular
endothelial cells and is localized in Weibel-Palade bodies. J Clin
Invest. 84:92–99. 1989. View Article : Google Scholar
|
|
24
|
Denis CV, André P, Saffaripour S and
Wagner DD: Defect in regulated secretion of P-selectin affects
leukocyte recruitment in von Willebrand factor-deficient mice. Proc
Natl Acad Sci USA. 98:4072–4077. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sundd P, Pospieszalska MK, Cheung LS,
Konstantopoulos K and Ley K: Biomechanics of leukocyte rolling.
Biorheology. 48:1–35. 2011.PubMed/NCBI
|
|
26
|
Palabrica T, Lobb R, Furie BC, Aronovitz
M, Benjamin C, Hsu YM, Sajer SA and Furie B: Leukocyte accumulation
promoting fibrin deposition is mediated in vivo by P-selectin on
adherent platelets. Nature. 359:848–851. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blann AD, Nadar SK and Lip GY: The
adhesion molecule P-selectin and cardiovascular disease. Eur Heart
J. 24:2166–2179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iannacone M, Sitia G, Narvaiza I, Ruggeri
ZM and Guidotti LG: Antiplatelet drug therapy moderates
immune-mediated liver disease and inhibits viral clearance in mice
infected with a replication-deficient adenovirus. Clin Vaccine
Immunol. 14:1532–1535. 2007. View Article : Google Scholar
|
